Latest News from CarThera
Frederic Sottilini MS MBA, a medical device professional, former Marketing Director at EDAP, General Manager at Accuray Europe and Business Manager at Philips, joined CarThera as the new CEO.
Dominique Costantini MD PhD, a pharmaceutical professional, founder of BioAlliance Pharma, joined CarThera as the new Chairman.
The first Clinical Advisory Board of CarThera was held in New York City on Febuary 13, 2014. It was a good opportunity to receive the various points-of-vue from different KOL experts (neuro-oncologists, neurosurgeons). All bring their support to CarThera’s developments, and are ready to participate in the future multi-centric pivotal study of SonoCloud, for which a protocole design has been defined.
CarThera and Theravectys were start-up examples in the innovation session with Denis Lucquin (Sofinnova), Pr Soffer (Technion Technology Transfert), Delphine Genny-Stephann (Saint-Gobain), Gilles Nobecourt (Rothschild), Jean Férré (Microsoft Fr), Renault Vaillant (Theravectys), and Pr Alexandre Carpentier (CarThera).
A Capital Magazine survey cited Alexandre Carpentier among the top 150 medical doctors in France, and among the top 10 neurosurgeons in France.
Alexandre Carpentier organized and animated the October 16th 2013 session of the academy, which was dedicated to “The future of surgery at the speed of ultrasound”. Dr. Carpentier’s speech was titled: “Interstitial Ultrasound: from Biopsy to Drug Delivery”.
June 2013: SonoCloud pre-clinical animal study results were published in the Journal of Neurosurgery.
June 2013: The mayor of Paris, Bertrand Delanoe, visited CarThera and the other startups at ICM.
Nov 2012 : CarThera was a finalist of the 2012 edition of the Grands Prix de la Ville de Paris, in the Health / Biotech category supported by PwC and Sanofi. Under the scientific leadership of Alexandre Carpentier MD PhD (Pierre & Marie Curie Professor of Neurosurgery at Sorbonne University Pitie-Salpetriere hospital), CarThera develops two complementary medical devices for brain disorders.
CarThera received on July 2, 2012 the “Start-up Espoir” Award from the Assistance Publique Hopitaux of Paris. Christian Lamoureux, the board director of the LEEM, and Mireille Faugère, the board director of AP-HP, with the French Patent Office and the CDC bank gave the “Trophée” to CarThéra representatives during the APinnov 2012 meeting.
At the 2012 annual meeting of the International Society for Therapeutic Ultrasound, Dr. Alexandre Carpentier was elected to the board as a clinical representative.
During the 2012 annual meeting of the International Society for Surgical Research, CarThera received the B.Braun Scientific Innovation Award, for the SonoCloud device “for an outstanding scientific work characterized by clinical relevance and applicability in daily clinical routine”
“Tous Innovateurs” : Carthera is a startup company, an academic research laboratory spin-off, that develops minimally-invasive medical technologies, under MRI guidance, that perform ultrasound therapies. Interview of Alexandre Carpentier MD PhD, its founder.
In 2010, CarThera was the laureate of the TECSAN (technologies for Health) grant program of the French National Agency for Research, for a three year grant from 2011-2013.
In 2008 and 2009, The French Ministry for Research awarded Alexandre Carpentier the national prize for innovative technologies, which was subsequently used to create a startup company based on his innovations.